These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 12073633)
21. Decision analysis for the cost-effective management of recurrent colorectal cancer. Park KC; Schwimmer J; Shepherd JE; Phelps ME; Czernin JR; Schiepers C; Gambhir SS Ann Surg; 2001 Mar; 233(3):310-9. PubMed ID: 11224617 [TBL] [Abstract][Full Text] [Related]
22. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. Lejeune C; Bismuth MJ; Conroy T; Zanni C; Bey P; Bedenne L; Faivre J; Arveux P; Guillemin F J Nucl Med; 2005 Dec; 46(12):2020-8. PubMed ID: 16330566 [TBL] [Abstract][Full Text] [Related]
23. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Huguet EL; Old S; Praseedom RK; Balan KK; Gibbs P; Jamieson NV Hepatogastroenterology; 2007 Sep; 54(78):1667-71. PubMed ID: 18019690 [TBL] [Abstract][Full Text] [Related]
24. PET/CT: will it change the way that we use CT in cancer imaging? Hicks RJ; Ware RE; Lau EW Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079 [TBL] [Abstract][Full Text] [Related]
25. Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Beets G; Penninckx F; Schiepers C; Filez L; Mortelmans L; Kerremans R; Aerts R; De Roo M Br J Surg; 1994 Nov; 81(11):1666-70. PubMed ID: 7827902 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077 [TBL] [Abstract][Full Text] [Related]
27. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases. Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727 [TBL] [Abstract][Full Text] [Related]
28. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. Delbeke D J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218 [TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Furukawa H; Ikuma H; Seki A; Yokoe K; Yuen S; Aramaki T; Yamagushi S Gut; 2006 Jul; 55(7):1007-11. PubMed ID: 16361308 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891 [TBL] [Abstract][Full Text] [Related]
32. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. Zealley IA; Skehan SJ; Rawlinson J; Coates G; Nahmias C; Somers S Radiographics; 2001 Oct; 21 Spec No():S55-69. PubMed ID: 11598248 [TBL] [Abstract][Full Text] [Related]
33. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. Kantorová I; Lipská L; Bêlohlávek O; Visokai V; Trubaĉ M; Schneiderová M J Nucl Med; 2003 Nov; 44(11):1784-8. PubMed ID: 14602860 [TBL] [Abstract][Full Text] [Related]
34. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up]. Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769 [TBL] [Abstract][Full Text] [Related]
35. Role of FDG-PET in surgical management of patients with colorectal liver metastases. Teague BD; Morrison CP; Court FG; Chin VT; Costello SP; Kirkwood ID; Maddern GJ ANZ J Surg; 2004 Aug; 74(8):646-52. PubMed ID: 15315564 [TBL] [Abstract][Full Text] [Related]
37. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer. Miller E; Lerman H; Gutman M; Figer A; Livshitz G; Even-Sapir E Invest Radiol; 2004 Jan; 39(1):8-12. PubMed ID: 14701983 [TBL] [Abstract][Full Text] [Related]
38. [Diagnosis of colorectal cancer with FDG-PET]. Uno K Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875 [No Abstract] [Full Text] [Related]
39. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related]
40. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]